Q97720209
motion by Amanda Palmstierna et al.. 2018
Press Enter · cited answer in seconds
0 sources
Q97720209
Summary
Q97720209 is an individual motion[1].
Key Facts
- Q97720209 authored Amanda Palmstierna[2].
- Q97720209 authored Rebecka Le Moine[3].
- Q97720209's instance of is recorded as individual motion[4].
- Q97720209's part of the series is recorded as motions of 2018-2019 legislative session of the Riksdag[5].
- Q97720209's language of work or name is recorded as Swedish[6].
- Q97720209's publication date is recorded as +2018-11-29T00:00:00Z[7].
- Q97720209's main subject is recorded as medication[8].
- Q97720209's work available at URL is recorded as http://data.riksdagen.se/dokument/H6022307[9].
- Q97720209's work available at URL is recorded as http://data.riksdagen.se/dokumentstatus/H6022307[10].
- Q97720209's applies to jurisdiction is recorded as Sweden[11].
- Q97720209's legal citation of this text is recorded as Mot. 2018/19:2307[12].
- Q97720209's title is recorded as Minskad miljöpåverkan från läkemedel[13].
- Q97720209's maintained by WikiProject is recorded as Project Riksdagen's documents[14].
- Q97720209's copyright status is recorded as public domain[15].
- Q97720209's legislative committee is recorded as Committee on Environment and Agriculture[16].
- Q97720209's Swedish Riksdag document ID is recorded as H6022307[17].
Body
Works and Contributions
Authored works include Amanda Palmstierna[2], a politician[18], b. 1977[19], of Sweden[20] and Rebecka Le Moine[3], a biologist[21], b. 1990[22], of Sweden[23].